Kunming Longjin Pharmaceutical Co Ltd
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial… Read more
Kunming Longjin Pharmaceutical Co Ltd (002750) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: -0.011x
Based on the latest financial reports, Kunming Longjin Pharmaceutical Co Ltd (002750) has a cash flow conversion efficiency ratio of -0.011x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.69 Million) by net assets (CN¥582.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kunming Longjin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Kunming Longjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kunming Longjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kunming Longjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT Black Diamond Resources Tbk
JK:COAL
|
-0.010x |
|
Hyprop
JSE:HYP
|
0.034x |
|
Lippo Cikarang Tbk
JK:LPCK
|
-0.030x |
|
Riverview Rubber Estates Bhd
KLSE:2542
|
0.032x |
|
Queen City Investments Inc
PINK:QUCT
|
N/A |
|
Air Industries Group
NYSE MKT:AIRI
|
0.000x |
|
Gumho NT Co Ltd
KQ:130500
|
0.006x |
|
Partner Tech Corp.
TWO:3097
|
N/A |
Annual Cash Flow Conversion Efficiency for Kunming Longjin Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥494.21 Million | CN¥-34.24 Million | -0.069x | +4.52% |
| 2023-12-31 | CN¥541.13 Million | CN¥-39.26 Million | -0.073x | -203.80% |
| 2022-12-31 | CN¥604.77 Million | CN¥-14.44 Million | -0.024x | -9.42% |
| 2021-12-31 | CN¥678.29 Million | CN¥-14.80 Million | -0.022x | -126.96% |
| 2020-12-31 | CN¥704.71 Million | CN¥-6.78 Million | -0.010x | -258.38% |
| 2019-12-31 | CN¥665.89 Million | CN¥4.04 Million | 0.006x | -87.44% |
| 2018-12-31 | CN¥655.93 Million | CN¥31.70 Million | 0.048x | -46.27% |
| 2017-12-31 | CN¥645.54 Million | CN¥58.06 Million | 0.090x | -42.15% |
| 2016-12-31 | CN¥670.46 Million | CN¥104.24 Million | 0.155x | +32.78% |
| 2015-12-31 | CN¥599.41 Million | CN¥70.19 Million | 0.117x | -52.34% |
| 2014-12-31 | CN¥285.57 Million | CN¥70.16 Million | 0.246x | -30.30% |
| 2013-12-31 | CN¥302.00 Million | CN¥106.46 Million | 0.353x | -12.24% |
| 2012-12-31 | CN¥226.94 Million | CN¥91.16 Million | 0.402x | -1.16% |
| 2011-12-31 | CN¥186.74 Million | CN¥75.90 Million | 0.406x | -- |